Growth Factors And Regulatory Genes Controlling Male Spermatogonial Proliferation And Differentiation.
Funder
National Health and Medical Research Council
Funding Amount
$354,536.00
Summary
In newborn and prepubertal boys the testis contains germ cells which are at a premature stage of development and very suseptible to degeneration especially if the testes fail to descend to the scrotum. The molecules which are responsible for the health of these germ cells have been unknown and only recently the way has been opened for direct study of these factors. This has been made possible by a new assay, developed in our labarotory, in which we can grow these germ cells under defined conditi ....In newborn and prepubertal boys the testis contains germ cells which are at a premature stage of development and very suseptible to degeneration especially if the testes fail to descend to the scrotum. The molecules which are responsible for the health of these germ cells have been unknown and only recently the way has been opened for direct study of these factors. This has been made possible by a new assay, developed in our labarotory, in which we can grow these germ cells under defined conditions. This step forward has highlighted some areas of knowledge which need further research such as identification of the processes which stimulate gonocytes to grow and divide. We need to test growth factors, somatic cell factors and also isolate new genes which are associated with germ cells and their growth. This knowledge will have outcomes in two major areas. First, the new findings could be applied to treatment of infertility resulting from undescended testes in which a stimulus could be given to make the germ cells grow again. Second, work in developing longer term culture of germ cells coupled with introduction of mutations will enable us to make mutant mice with a specific gene abnormality, similar to transgenic or gene knockout mice. This technological development would prove less expensive and time consuming with more reproducible and direct outcomes. Mutant mouse technology is a powerful tool to determine the effects of individual genes in the whole animal (mouse).Read moreRead less
Identification And Characterisation Of Cells With High Proliferative Potential In Human Endometrium
Funder
National Health and Medical Research Council
Funding Amount
$409,575.00
Summary
Each month when the uterine lining does not receive an implanting embryo, this lining is shed as part of the menstrual process. It is rapidly replaced with a new functional lining that grows from the basal layer that remains. In post menopausal women, who only have the thin basal layer of the uterine lining, there is rapid regeneration of the lining when they commence hormone replacement therapy. Despite this remarkable regenerative capacity of the uterine lining, nothing is known about the prec ....Each month when the uterine lining does not receive an implanting embryo, this lining is shed as part of the menstrual process. It is rapidly replaced with a new functional lining that grows from the basal layer that remains. In post menopausal women, who only have the thin basal layer of the uterine lining, there is rapid regeneration of the lining when they commence hormone replacement therapy. Despite this remarkable regenerative capacity of the uterine lining, nothing is known about the precursor cells responsible for its cyclical growth. Our preliminary studies have shown that the human uterine lining contains a rare population of cells with high proliferative capacity. This project will identify, characterize and locate these precursor cells in the human uterine lining. It also aims to obtain information on how these precursor cells function in regenerating the uterine lining, how they interact with sex hormones and how their proliferative activity is regulated. Information generated from this project will provide significant new insight into the functioning of the uterine lining. It also has immediate application to common gynaecological diseases associated with abnormal growth of the uterine lining, such as endometriosis, a disease which affects 10% of reproductive age women causing pain and infertility. A better understanding of how these precursor cells may be involved in endometriosis and other gynaecological diseases may ultimately lead to the development of improved medical treatments rather than surgical intervention, which is currently the main form of treatment.Read moreRead less
Lung Epithelial Stem Cells In Chronic Respiratory Disease
Funder
National Health and Medical Research Council
Funding Amount
$586,965.00
Summary
The World Health Organisation estimates that by 2020, 12 of 68 million deaths worldwide will be attributed to lung disease with Chronic Obstructive Pulmonary Disease ranked the 3rd leading cause of death. Current therapies are palliative, providing symptomatic relief but no prospect of cure. In this project, we aim to determine how the ability of lung stem cells to repair the lung is compromised in disease in order to develop innovative therapies to arrest or reverse the disease process.
Development Of A Sensitive Point Of Care Diagnostic Assay For Troponin I
Funder
National Health and Medical Research Council
Funding Amount
$137,650.00
Summary
This research aims to develop a diagnostic for immediate monitoring of patients presenting with chest pain, with the presumption of heart attack. The novel diagnostic platform will enable the estimation of a key indicator of heart muscle damage to be performed within a ten to fifteen minute window. This will aid speedier diagnosis and propoer triage of patients presenting with chest pain.
Culture-independent Microbiology: Reducing Delays In The Diagnosis Of Severe Infections And Detection Of Antimicrobial Resistance From Days To Hours.
Funder
National Health and Medical Research Council
Funding Amount
$949,589.00
Summary
Serious infections require early effective antibiotic treatment. To provide evidence that an antibiotic will be effective, current tests take 2-5 days and this leads to a reliance on broad spectrum antibiotics, which can cause harm. Our new diagnostic methods, can produce results in 4-6 hours. We will demonstrate the real-world benefit of these methods by assessing samples taken from patients with three high risk infections and compare our test to currently available results.
Novel Genes And Protein In Non-alcoholic Fatty Liver Disease: Potential Basis Of A Serum-based Assessment Of Disease Sta
Funder
National Health and Medical Research Council
Funding Amount
$200,000.00
Summary
The most common cause of elevated liver function tests is non-alcoholic fatty liver disease (NAFLD). NALFD is a spectrum of disease ranging from steatosis, to non-alcoholic steatohepatitis (NASH), a condition associated with the development of fibrosis in the majority of individuals. Approximately 20% and 3% of adults are affected with NAFLD and NASH, respectively, and NAFLD is expected to become the next major liver epidemic facing the western world, far exceeding the prevalence of chronic infe ....The most common cause of elevated liver function tests is non-alcoholic fatty liver disease (NAFLD). NALFD is a spectrum of disease ranging from steatosis, to non-alcoholic steatohepatitis (NASH), a condition associated with the development of fibrosis in the majority of individuals. Approximately 20% and 3% of adults are affected with NAFLD and NASH, respectively, and NAFLD is expected to become the next major liver epidemic facing the western world, far exceeding the prevalence of chronic infection with the hepatitis C virus. We obtained liver biopsies from patients with NAFLD, 80% of whom had NASH, and determined the expression profile analysis of each subject using 19,200 element microarrays. Our data demonstrates the concordant differential expression of 130 genes, in subjects with NAFLD that were categorizes into 6 major metabolic and regulatory pathways. Many of these genes represented uncharacterised genes. Utilising an extensive bioinformatics approach we have been able to define the genes and their protein product. The use of these proteins as a diagnostic tool for the detection of NAFLD forms the basis of a provisional patent application. However, measurements of protein levels in tissue and sera from patients with NAFLD are needed for the development of a diagnostic method. Such information would also provide significant insight into the pathogenesis of NAFLD. The AIMS are: 1) Production of antibodies against proteins encoded by candidate genes Expression profile of candidate genes 3) Expression of proteins encoded by candidate genes in patients with NAFLDRead moreRead less